Next Article in Journal
Response to John G. Brock-Utne. Comment on Hurley, J.C. Towards Clinical Application of Anti-endotoxin Antibodies; A Re-Appraisal of the Disconnect
Previous Article in Journal
An N-Terminal Fragment of Yeast Ribosomal Protein L3 Inhibits the Cytotoxicity of Pokeweed Antiviral Protein in Saccharomyces cerevisiae
Reply published on 11 April 2014, see Toxins 2014, 6(4), 1364-1365.

Comment of Toxins 2013, 5(12), 2589-2620.

Toxins 2014, 6(4), 1362-1363; doi:10.3390/toxins6041362
Comment

Comment on Hurley, J.C. Towards Clinical Application of Anti-endotoxin Antibodies; A Re-Appraisal of the Disconnect. Toxins 2013, 5, 2589-2620

Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine Stanford, CA 94305, USA
Received: 20 March 2014 / Accepted: 9 April 2014 / Published: 11 April 2014
View Full-Text   |   Download PDF [132 KB, uploaded 11 April 2014]

Abstract

I have read with interest James C. Hurley’s very good review [1].
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).
SciFeed

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
RIS
MDPI and ACS Style

Brock-Utne, J.G. Comment on Hurley, J.C. Towards Clinical Application of Anti-endotoxin Antibodies; A Re-Appraisal of the Disconnect. Toxins 2013, 5, 2589-2620. Toxins 2014, 6, 1362-1363.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

[Return to top]
Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert